PURPOSE: Sterile corneal infiltrates can cause pain, blurred vision, and ocular discomfort in silicone hydrogel contact-lens users. The current study investigates the potential for the synthetic lymphocyte functional antigen-1 (LFA-1) antagonist lifitegrast (SAR 1118) to block corneal inflammation using a murine model. METHODS: The role of LFA-1 (CD11a/CD18) was examined either in CD18(-/-) mice, by intraperitoneal injection of anti-CD11a, or by topical application of lifitegrast. Corneal inflammation was induced by epithelial abrasion and exposure to either tobramycin-killed Pseudomonas aeruginosa or Staphylococcus aureus in the presence of a 2-mm-diameter punch from a silicone hydrogel contact lens. After 24 h, corneal thickness and haze were examined by in vivo confocal microscopy, and neutrophil recruitment to the corneal stroma was detected by immunohistochemistry. RESULTS: Neutrophil recruitment to the corneal stroma and development of stromal haze were significantly impaired in CD18(-/-) mice or after injection of anti-CD11a. Topical lifitegrast also inhibited P. aeruginosa- and S. aureus-induced inflammation, with the optimal application being a 1% solution applied either 2 or 3 times prior. CONCLUSION: As LFA-1-dependent neutrophil recruitment to the corneal stroma can be blocked by topical lifitegrast, this reagent could be used in combination with antibiotics to prevent leukocyte infiltration to the corneal stroma in association with contact-lens wear.
PURPOSE: Sterile corneal infiltrates can cause pain, blurred vision, and ocular discomfort in silicone hydrogel contact-lens users. The current study investigates the potential for the synthetic lymphocyte functional antigen-1 (LFA-1) antagonist lifitegrast (SAR 1118) to block corneal inflammation using a murine model. METHODS: The role of LFA-1 (CD11a/CD18) was examined either in CD18(-/-) mice, by intraperitoneal injection of anti-CD11a, or by topical application of lifitegrast. Corneal inflammation was induced by epithelial abrasion and exposure to either tobramycin-killed Pseudomonas aeruginosa or Staphylococcus aureus in the presence of a 2-mm-diameter punch from a silicone hydrogel contact lens. After 24 h, corneal thickness and haze were examined by in vivo confocal microscopy, and neutrophil recruitment to the corneal stroma was detected by immunohistochemistry. RESULTS: Neutrophil recruitment to the corneal stroma and development of stromal haze were significantly impaired in CD18(-/-) mice or after injection of anti-CD11a. Topical lifitegrast also inhibited P. aeruginosa- and S. aureus-induced inflammation, with the optimal application being a 1% solution applied either 2 or 3 times prior. CONCLUSION: As LFA-1-dependent neutrophil recruitment to the corneal stroma can be blocked by topical lifitegrast, this reagent could be used in combination with antibiotics to prevent leukocyte infiltration to the corneal stroma in association with contact-lens wear.
Authors: Loretta Szczotka-Flynn; Jonathan H Lass; Ajay Sethi; Sara Debanne; Beth Ann Benetz; Matthew Albright; Beth Gillespie; Jana Kuo; Michael R Jacobs; Alfred Rimm Journal: Invest Ophthalmol Vis Sci Date: 2010-06-10 Impact factor: 4.799
Authors: Vidhya R Rao; Elizabeth Prescott; Namdev B Shelke; Ruchit Trivedi; Peter Thomas; Craig Struble; Tom Gadek; Charles A O'Neill; Uday B Kompella Journal: Invest Ophthalmol Vis Sci Date: 2010-05-05 Impact factor: 4.799
Authors: Charles P Semba; Dennis Swearingen; Valerie L Smith; Mary S Newman; Charles A O'Neill; John P Burnier; David B Haughey; Thomas R Gadek Journal: J Ocul Pharmacol Ther Date: 2010-03-24 Impact factor: 2.671
Authors: Christopher J Murphy; Ellison Bentley; Paul E Miller; Kim McIntyre; Gary Leatherberry; Richard Dubielzig; Elizabeth Giuliano; Cecil P Moore; Thomas E Phillips; Peter B Smith; Elizabeth Prescott; Jacqueline M Miller; Peter Thomas; Randall Scagliotti; Doug Esson; Tom Gadek; Charles A O'Neill Journal: Invest Ophthalmol Vis Sci Date: 2011-05-16 Impact factor: 4.799
Authors: Yan Sun; Mausita Karmakar; Sanhita Roy; Raniyah T Ramadan; Susan R Williams; Scott Howell; Carey L Shive; Yiping Han; Charles M Stopford; Arne Rietsch; Eric Pearlman Journal: J Immunol Date: 2010-09-08 Impact factor: 5.422
Authors: Debjani Gagen; Sara Laubinger; Zhijie Li; Matei S Petrescu; Evelyn S Brown; C Wayne Smith; Alan R Burns Journal: Exp Eye Res Date: 2010-08-14 Impact factor: 3.467
Authors: Eric Pearlman; Angela Johnson; Gautam Adhikary; Yan Sun; Holly R Chinnery; Todd Fox; Mark Kester; Paul G McMenamin Journal: Ocul Surf Date: 2008-07 Impact factor: 5.033
Authors: Saloni Khatri; Jonathan H Lass; Fred P Heinzel; W Matthew Petroll; John Gomez; Eugenia Diaconu; Carolyn M Kalsow; Eric Pearlman Journal: Invest Ophthalmol Vis Sci Date: 2002-07 Impact factor: 4.799
Authors: Eric Pearlman; Yan Sun; Sanhita Roy; Mausita Karmakar; Amy G Hise; Loretta Szczotka-Flynn; Mahmoud Ghannoum; Holly R Chinnery; Paul G McMenamin; Arne Rietsch Journal: Int Rev Immunol Date: 2013-02 Impact factor: 5.311
Authors: Eric D Donnenfeld; Paul M Karpecki; Parag A Majmudar; Kelly K Nichols; Aparna Raychaudhuri; Monica Roy; Charles P Semba Journal: Cornea Date: 2016-06 Impact factor: 2.651
Authors: Laura M Periman; Victor L Perez; Daniel R Saban; Meng C Lin; Piergiorgio Neri Journal: J Ocul Pharmacol Ther Date: 2020-03-12 Impact factor: 2.671